References
- Tabár L, Vitak B, Chen TH, . Swedish Two-County Trial: Impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260:658–63
- Jacoby VL, Grady D, Wactawski-Wende J, . Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011;171: 760–8
- Sanmuganathan P, Ghahramani P, Jackson P, Wallis E, Ramsay L. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2001;85: 265–71
- Riancho JA. Number of patients to be treated and number of prevented fractures: clinical efficiency of osteoporosis treatment with diphosphonate alendronate. Rev Clin Esp 1999;199:349–55
- The National Osteoporosis Foundation. Review of the evidence for prevention, diagnosis and treatment and cost-effective analysis. Osteoporos Int 1998;8(Suppl 4):S53–5
- Wisløff T, Aalen OO, Kristiansen IS. Considerable variation in NNT – a study based on Monte Carlo simulations. J Clin Epidemiol 2011;64:444–50
- Suissa D, Brassard P, Smiechowski B, Suissa S. Number needed to treat is incorrect without proper time-related considerations. J Clin Epidemiol 2012;65:42–6
- Rossouw JE, Anderson GL, Prentice RL, . The Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–23